#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Sjogren's syndrome Arterial disorder Chordoma Bone marrow disorder Inclusion body myositis B-cell type acute leukaemia Dementia with Lewy bodies Mitochondrial DNA depletion Fibrosarcoma Oesophageal achalasia Fungal infection Systemic scleroderma Scedosporium infection Chronic myelomonocytic leukaemia Anal cancer More trials…

    Learn about Rare Diseases

    Synovial sarcoma recurrent – Basic Information Krabbe’s disease – Trials in Disease Stevens-Johnson syndrome – Basic Information Retinitis pigmentosa – Life with Disease Mantle cell lymphoma refractory – Diagnostics Glycogen storage disease type V Pulmonary fibrosis Langerhans cell sarcoma – Basic Information Ewing’s sarcoma recurrent – Treatment Marginal zone lymphoma refractory – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Idelalisib Pegenzileukin Vinblastine Sulfate Alpelisib Isosorbide Dinitrate AZD3632 PRILOCAINE HYDROCHLORIDE Aup1602-C Triptorelin Cholic Acid Diclofenac Diethylamine HUMAN PLASMA Mbs2320 Zalunfiban Biotin Estriol Jk08 Emraclidine Perindopril Arginine Imifoplatin More therapies…

    Learn about Your Condition

    Haemodialysis Menopause Mitral valve prolapse Vulvovaginal dryness Krabbe's disease Ocular hypertension Haemorrhagic stroke Vaginal infection Osteopenia Latent tuberculosis Hypervolaemia Ligament sprain Post-acute COVID-19 syndrome Immune-mediated enterocolitis KBG syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Hopital Saint Antoine

Hopital Saint Antoine

184 Rue Du Faubourg Saint Antoine, Paris, 75571, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study of M9140 for Patients with Advanced Non-Small Cell Lung Cancer

    Not recruiting

    1 1 1
    Austria France Germany Italy Spain

  • Study of M9140 for Patients with Advanced Stomach Cancer

    Not recruiting

    1 1 1
    Austria France Germany Italy Spain

  • Study on NTLA-2002 for Treating Hereditary Angioedema in Patients: Evaluating the Effects of Ziclumeran and Lonvoguran

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Lonvoguran
    • Sodium Chloride
    • Ziclumeran
    France Germany The Netherlands

  • Study on the Effectiveness of Tocilizumab, Methylprednisolone, and Prednisone for Patients with Acute Anterior Ischemic Optic Neuropathy in Giant Cell Arteritis

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Methylprednisolone Hemisuccinate
    • Prednisone
    • Tocilizumab
    France

  • Study of Deucrictibant Extended-Release Tablets for Prevention of Hereditary Angioedema Attacks in Adults and Adolescents

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hereditary angioedema
    Investigated Drugs:
    • Deucrictibant
    • Icatibant
    Bulgaria France Germany Hungary Ireland Italy +4

  • Study on Chemotherapy with Levoleucovorin, Capecitabine, and Folinic Acid for Patients Aged 70+ After Stage III Colon Cancer Surgery

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Colon cancer
    Investigated Drugs:
    • Levoleucovorin
    • Folinic Acid
    • Capecitabine
    Belgium France

  • Study Comparing Lenalidomide, Daratumumab, and Dexamethasone for Frail Patients with Untreated Multiple Myeloma Not Eligible for High-Dose Therapy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Daratumumab
    • Dexamethasone
    • Lenalidomide
    Belgium France

  • Study on FX06 for Improving Acute Respiratory Distress Syndrome in Patients

    Not recruiting

    2 1
    Investigated Diseases:
    • Acute respiratory distress syndrome
    Investigated Drugs:
    • Glutenin
    France Germany Lithuania Romania Spain

  • Study on the Safety and Effectiveness of TAK-755 (Apadamtase Alfa) for Patients with Severe Congenital Thrombotic Thrombocytopenic Purpura (cTTP)

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Thrombotic thrombocytopenic purpura
    Investigated Drugs:
    • Apadamtase Alfa
    Austria France Germany Italy Poland Spain

  • Study of Encorafenib, Cetuximab, and Pembrolizumab for Patients with Untreated BRAF V600E-Mutant Metastatic Colorectal Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    • Colorectal cancer
    Investigated Drugs:
    • Cetuximab
    • Encorafenib
    • Pembrolizumab
    Belgium Czechia Denmark France Germany Italy +6
Previous Page
1 … 7 8 9 10 11 … 15
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!